Navigation Links
Opiate cocktail may spare cells from morphine's dark side

Although morphine is well known as a highly effective analgesic, its clinical utility is severely limited by the development of drug tolerance, the requirement for increasing doses to maintain analgesic effect, and the development of physical dependence. In the June 7 issue of Current Biology, researchers report a new study showing that the administration of a drug cocktail containing morphine along with small doses of two versions of methadone, a related opioid drug, significantly reduced both tolerance and dependence in test animals.

The work is reported by Li He and Jennifer Whistler of the Ernest Gallo Clinic and Research Center and the University of California, San Francisco.

The analgesic effects of morphine arise through the interaction of the drug with a specialized protein on the surface of cells, the mu opioid peptide receptor, or "MOP" receptor. MOP receptors are also activated by other opioid drugs and by endogenous opioids, such as endorphins. However, morphine is unique in that unlike other opioids, it does not cause the MOP receptor to be internalized into the cell's interior after activation. It is thought that the activated receptor's persistence at the cell surface leads to a compensatory overactivation of a particular signaling pathway in the cell--a signaling imbalance that is a hallmark of opiate tolerance and dependence. This suggests that the promotion of MOP-receptor internalization might prevent such cellular signaling imbalances, and indeed past work from Whistler indicated that mutant versions of the receptor that are more readily internalized were associated with reduced levels of morphine tolerance in mice.

In the new work, the researchers sought a more clinically practical approach to facilitating MOP-receptor internalization in the presence of morphine. Reasoning that because other opioid drugs promote internalization of MOP receptors, and that their presence in combination with morphine may prevent the persisten ce of activated MOP receptors at the cell surface, the authors developed a drug cocktail containing morphine along with two chemical versions of the opioid methadone, which is tolerated, with limited side effects, at low doses.

The authors indeed found that the combination of morphine with the methadone mixture prevented the activation of cellular signaling pathways associated with morphine tolerance and dependence. They also showed, perhaps most importantly, that whereas rats receiving only morphine develop tolerance to the drug, those rats receiving the morphine/methadone cocktail did not show tolerance. Moreover, past work has not indicated whether the promotion of MOP-receptor internalization could prevent the development of morphine dependence, but in the new study, the authors discovered that rats receiving the morphine/methadone cocktail also experienced reduced morphine dependence.

In light of their findings, the authors propose that an opiate cocktail that combines morphine with small doses of methadone would increase the effectiveness of morphine for the treatment of chronic pain.

He, L., and Whistler, J.L. (2005). An Opiate Cocktail that Reduces Morphine Tolerance and Dependence. DOI 10.1016/j.cub.2005.04.052 Publishing in Current Biology, Vol. 15, June 7, 2005, pages 1028?033. www.current-biology.com


'"/>

Source:Cell Press


Related biology news :

1. Opiates Better Than Sedatives For Treating Newborns In Withdrawal
2. Environmental chemical cocktail may sabotage sperm
3. Strawberry daiquiris -- the extra-healthy cocktail?
4. The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life
5. Could better mangrove habitats have spared lives in the 2004 tsunami?
6. Scientists discover why cornea is transparent and free of blood vessels, allowing vision
7. Wisconsin scientists grow critical nerve cells
8. Spleen may be source of versatile stem cells
9. Researchers discover way to make cells in the eye sensitive to light
10. Priming embryonic stem cells to fulfill their promise
11. Lack of enzyme turns fat cells into fat burners
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2017)... LLC , a medical device company focused on improving the safety ... ISO 13485 Certification, the global standard for medical device quality management ... ... for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates our ...
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
Breaking Biology Technology: